Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 5 studies | 22% ± 9% | |
microglial cell | 4 studies | 22% ± 3% |
Insufficient scRNA-seq data for expression of GAL3ST4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 99% | 2181.08 | 1796 / 1809 | 99% | 52.73 | 466 / 472 |
brain | 93% | 407.89 | 2453 / 2642 | 100% | 46.56 | 705 / 705 |
breast | 93% | 477.65 | 426 / 459 | 98% | 21.16 | 1097 / 1118 |
uterus | 100% | 1177.95 | 170 / 170 | 89% | 15.61 | 410 / 459 |
ovary | 100% | 754.33 | 180 / 180 | 88% | 15.19 | 379 / 430 |
intestine | 99% | 665.13 | 957 / 966 | 85% | 10.58 | 450 / 527 |
lung | 92% | 633.70 | 530 / 578 | 89% | 14.65 | 1028 / 1155 |
bladder | 100% | 791.86 | 21 / 21 | 80% | 11.68 | 402 / 504 |
esophagus | 98% | 637.58 | 1423 / 1445 | 78% | 11.12 | 143 / 183 |
prostate | 98% | 606.33 | 241 / 245 | 62% | 4.44 | 310 / 502 |
stomach | 55% | 174.81 | 199 / 359 | 87% | 11.06 | 250 / 286 |
adrenal gland | 89% | 429.72 | 230 / 258 | 47% | 4.21 | 109 / 230 |
thymus | 70% | 220.75 | 460 / 653 | 53% | 13.52 | 323 / 605 |
kidney | 39% | 109.52 | 35 / 89 | 82% | 14.39 | 743 / 901 |
pancreas | 17% | 55.37 | 56 / 328 | 91% | 13.21 | 162 / 178 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.64 | 45 / 45 |
spleen | 99% | 373.89 | 238 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 810.61 | 1288 / 1335 | 0% | 0 | 0 / 0 |
adipose | 92% | 505.54 | 1108 / 1204 | 0% | 0 | 0 / 0 |
heart | 74% | 290.18 | 634 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 4.24 | 15 / 29 |
peripheral blood | 44% | 143.66 | 407 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 3.09 | 27 / 80 |
liver | 4% | 12.64 | 10 / 226 | 20% | 2.07 | 83 / 406 |
muscle | 13% | 30.52 | 105 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007267 | Biological process | cell-cell signaling |
GO_0030166 | Biological process | proteoglycan biosynthetic process |
GO_0009100 | Biological process | glycoprotein metabolic process |
GO_0009247 | Biological process | glycolipid biosynthetic process |
GO_0006790 | Biological process | sulfur compound metabolic process |
GO_0009101 | Biological process | glycoprotein biosynthetic process |
GO_0009311 | Biological process | oligosaccharide metabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0016020 | Cellular component | membrane |
GO_0050656 | Molecular function | 3'-phosphoadenosine 5'-phosphosulfate binding |
GO_0050698 | Molecular function | proteoglycan sulfotransferase activity |
GO_0001733 | Molecular function | galactosylceramide sulfotransferase activity |
GO_0050694 | Molecular function | galactose 3-O-sulfotransferase activity |
Gene name | GAL3ST4 |
Protein name | Galactose-3-O-sulfotransferase 4 (Gal3ST-4) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 4) (Gal-beta-1,3-GalNAc 3'-sulfotransferase) Galactose-3-O-sulfotransferase 4 |
Synonyms | PP6968 |
Description | FUNCTION: Catalyzes the transfer of sulfate to beta-1,3-linked galactose residues in O-linked glycoproteins. Good substrates include asialofetuin, Gal-beta-1,3-GalNAc and Gal-beta-1,3 (GlcNAc-beta-1,6)GalNAc. . |
Accessions | ENST00000498000.5 Q96RP7 ENST00000482469.5 C9IZ77 A0A0J9YYD8 A0A0J9YVN4 A0A0J9YXX0 ENST00000460995.2 ENST00000360039.9 [Q96RP7-1] ENST00000411994.1 ENST00000413800.5 [Q96RP7-1] ENST00000423751.2 |